Trials / Withdrawn
WithdrawnNCT03664466
Astaxanthin Effects on Osteoarthritis Associated Pain and Inflammatory Indicators
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Saint Luke's Health System · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is intended to assess the effects of astaxanthin use on pain, physical function, and inflammation as reflected by Patient-Reported Outcomes Measurement Information System (PROMIS) scores and levels of inflammatory biomarkers in subjects taking astaxanthin. If improvements in pain, function, and/or markers of inflammation could be demonstrated with the use of astaxanthin, this may suggest the potential for astaxanthin to be used in management of knee osteoarthritis (and possibly other forms of osteoarthritis) with less evident toxicity than seen with the presently available standard therapies (e.g. NSAIDS, opioids).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | astaxanthin | astaxanthin capsules 12 mg twice daily |
| OTHER | Placebo | placebo capsules twice daily |
Timeline
- Start date
- 2021-04-29
- Primary completion
- 2022-01-25
- Completion
- 2022-01-25
- First posted
- 2018-09-10
- Last updated
- 2022-04-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03664466. Inclusion in this directory is not an endorsement.